Highlights
- Promisia Healthcare reported strong FY26 Revenue, profit, and occupancy growth.
- The company introduced a new Dividend policy linked to operating free Cash Flow.
- Promisia expects further Earnings growth and potential acquisitions in FY27.
Overview
Promisia Healthcare Limited (NZX:PHL) delivered a strong financial and operational performance for the year ended 31 March 2026, supported by higher occupancy, improved cash flow, and stronger operational efficiency across its care facilities. Operating Revenue rose significantly during the year, while underlying EBITDAF and net profit after tax also recorded robust growth. The company strengthened its Balance Sheet through a Debt restructure and lower borrowing costs, while occupancy levels improved across the portfolio. Promisia also introduced a formal dividend policy tied to operating free cash flow, reflecting confidence in future cash generation and Long-term Growth opportunities.
How Did Promisia Strengthen Its FY26 Financial Performance?
Promisia Healthcare achieved strong growth across its major financial indicators during FY26, driven by higher occupancy rates, contributions from the Cromwell operations, and increased deferred management fees. The company also benefited from valuation gains across its care facilities and retirement villages, with every site recording an increase in value during the year.
The company’s balance sheet position improved following a comprehensive debt restructure that simplified funding arrangements and reduced borrowing costs. Loan-to-value ratios declined significantly, while net tangible assets per share recorded notable growth. Management indicated that lower financing costs are expected to provide further support to earnings and cash flow performance in FY27.
Why Is Promisia Optimistic About FY27 Growth?
Promisia enters FY27 with stronger occupancy levels, improved operational systems, and enhanced cash generation capability. The company expects further growth in underlying EBITDAF, supported by stable Demand for aged care and retirement living services. Occupancy across the group is projected to improve further as operational efficiencies continue to strengthen.
The Board also introduced a dividend policy based on operating free cash flow, highlighting confidence in the Business’s financial position. In addition, Promisia is actively pursuing an earnings-accretive Acquisition aligned with its integrated care and retirement village strategy. Management believes the stronger financial platform created in FY26 positions the company well for disciplined expansion and sustainable long-term growth.
FAQs
Q: Why did Promisia Healthcare report stronger FY26 results?
A: The company benefited from higher occupancy, stronger operational performance, improved cash flow, and valuation gains across its facilities.
Q: What is Promisia’s new dividend policy?
A: Promisia introduced a dividend policy linked to operating free cash flow, with dividends expected to range between 20% and 40% of available cash flow.
Q: What is Promisia expecting in FY27?
A: The company expects further earnings growth, stronger cash flow, higher occupancy, and potential acquisition opportunities during FY27.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
This report (“Report”) has been issued by Kalkine New Zealand Limited (FSP691351) (NZBN:9429047678101) (“Kalkine”). Kalkine is a Financial Advice Provider (“FAP”) and is authorised by a Class 1 Financial Advice Provider Licence issued by Financial Markets Authority (“FMA”) to provide financial advice. Kalkine provides only general financial advice through its research reports following a person becoming a member. The reports contain buy/sell/hold and other recommendations in relation to equity securities, managed funds and other managed investment schemes and other financial advice products. The recommendations and opinions in this Report and on Kalkine website do not take into account any of your investment objectives, financial situation or needs. Before you make a decision about whether to acquire a financial product, you should obtain the Product Disclosure Statement from the product issuer. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. If you act on the advice in the research reports, you may have to pay fees, expenses or other amounts (but not to Kalkine).
The information in this Report and on the Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its reports (including this Report), newsletters and websites. All information represents our views at the date of publication and may change without notice.
Kalkine does not issue, sell or deal in any financial products. The information in this Report does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products. Our reports contain general recommendations to invest in securities and other financial products. Kalkine is not responsible for, and does not guarantee, the performance of, or returns on, any investments mentioned in this Report.
This Report may contain information on past performance of particular investments. Past performance is not a reliable indicator of future performance. Returns stated do not take into account transaction costs and taxes.
Further information about the complaints and dispute resolution process, as well as information about Kalkine’s duties are available on Kalkine’s website. Please read our Financial Advice Provider (FAP) disclosure statement and Complaints Handling Guide, which are available on the website.
Copyright 2026 Krish Capital Pty. Ltd. (ABN 61629651510). All Rights Reserved. No part of this Report, or its content, may be reproduced in any form without our prior consent.